Your trusted source for investing success
In case you missed it, here is this week’s big news roundup in Technology.
Krystal Biotech (NASDAQ:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announces that KB103, a gene therapy candidate for dystrophic epidermolysis bullosa (“DEB”), was granted Orphan Medicinal Product Designation (OMPD) from the European Medicines Agency (EMA). KB103 represents the first
Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF) (“Maricann” or the “Company”), is pleased to announce that the first seeds will be planted today on its contract farmed 164 hectares (~405 acre) of agricultural land in Saxony, Germany, through Mariplant GmbH a 95% owned subsidiary of the Company focused on nutraceutical non-THC cannabis.
vTv Therapeutics, Teligent, EyePoint Pharmaceuticals, Catalyst Biosciences and Eleven Biotherapeutics were last week’s top gainers.
Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week’s top gainers.
Emergent BioSolutions (NYSE:EBS) announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU), including Italy, the Netherlands, Poland, the U.K., and France (where it will be marketed as BaciThrax™). Emergent filed the
Boreal Metals Corp. (“Boreal” or the “Company”) (TSXV:BMX) is pleased to announce the execution of a definitive agreement (the “Agreement”) with EMX Royalty Corporation (“EMX”) (NYSE American: EMX, TSXV: EMX) for the acquisition of the Mjövattnet and Njuggträskliden cobalt and nickel projects (the “Projects”) by Boreal Energy Metals Corp. (“BEMC”),
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) providing claims that protect processes for making specific compositions of matter for enhanced cannabinoid delivery utilizing its DehydraTECH(TM) technology.
By Amanda Kay
Phosphate-mining production is expected to grow by 2 percent through 2020. Find out which countries produced the most phosphate last year.
Velocity Minerals Ltd. (TSXV:VLC) (“Velocity” or the “Company”) announces that it has filed a NI 43-101 Technical Report on SEDAR (the “Report”) entitled “NI 43-101 Technical Report; Mineral Resource Estimation for the Rozino Gold Deposit, Republic of Bulgaria”, dated 5 April 2018 (effective date March 21, 2018).
By Amanda Kay
China is the largest producer of rare earths by far, but what are the other top countries for rare earths production? Find out here.
Cardiome, Avid, XBiotech, Fennec and Compugen were last week’s five top-gaining NASDAQ biotech stocks. See what moved their share prices.
Overall zinc mine production is due to climb 6 percent this year to 13.78 million tonnes, the International Lead and Zinc Study Group says.
Velocity Minerals Ltd. (TSXV:VLC) (“Velocity” or the “Company”) announces that it has received additional positive assay results from step-out drilling at East Zone, Rozino gold project, with all 2018 drill holes intersecting gold mineralization.
DELTA 9 CANNABIS INC. (TSXV:NINE) (“Delta 9” or the “Company”) is pleased to announce that the Company has signed a non-binding letter of intent (the “LOI”) with CanPharma GMBH (“CanPharma”) and Global Group Kalapa S.L. (“Kalapa”) for the exportation of medical cannabis to Germany.
Velocity Minerals Ltd. (TSXV:VLC) (“Velocity” or the “Company”) announces a non-brokered private placement (the “Financing”) of up to 17,500,000 units (the “Units”) priced at $0.20 per Unit to raise total gross proceeds of up to $3.5 million.
Velocity Minerals Ltd. (TSXV:VLC) (“Velocity” or the “Company”) reports results of bottle roll and stirred leach tests carried out on various grades of mineralized samples from the Rozino gold project (“Rozino”), located in southeast Bulgaria. The test results show gold recoveries up to 92.9%. Test work was completed
Second Sight, Juniper, Athersys, Aptose and ArQule were last week’s five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March has been a busy month for Biogen with its voluntary withdrawal of Zinbryta and its acquisition of Pfizer’s PF-04958242.
By Amanda Kay
What are the pros and cons of owning silver bullion? With tension ramping up worldwide now may be the time for investors to enter the market.
Connect with our Featured Silver Stocks to receive the latest news and investor presentations.
